Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Nephritis | 6 | 2024 | 77 | 1.920 |
Why?
|
| Lupus Erythematosus, Systemic | 7 | 2024 | 211 | 1.510 |
Why?
|
| Rheumatology | 1 | 2023 | 35 | 0.860 |
Why?
|
| Nephritis, Interstitial | 3 | 2020 | 44 | 0.840 |
Why?
|
| Autoantibodies | 6 | 2021 | 268 | 0.600 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 196 | 0.510 |
Why?
|
| Lymphocytes | 1 | 2016 | 471 | 0.480 |
Why?
|
| Kidney | 6 | 2022 | 1147 | 0.450 |
Why?
|
| Internship and Residency | 1 | 2023 | 1045 | 0.450 |
Why?
|
| Interferon-alpha | 2 | 2012 | 226 | 0.410 |
Why?
|
| Antibodies, Antinuclear | 1 | 2012 | 83 | 0.400 |
Why?
|
| Inflammation | 5 | 2022 | 972 | 0.400 |
Why?
|
| Apoptosis | 1 | 2016 | 1717 | 0.350 |
Why?
|
| Vimentin | 2 | 2020 | 46 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 2340 | 0.230 |
Why?
|
| Graft Rejection | 2 | 2021 | 1070 | 0.220 |
Why?
|
| Faculty | 1 | 2023 | 33 | 0.220 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 850 | 0.200 |
Why?
|
| Palatine Tonsil | 2 | 2021 | 30 | 0.190 |
Why?
|
| Allografts | 1 | 2021 | 181 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2023 | 871 | 0.180 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 393 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 739 | 0.160 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 277 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 414 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2023 | 784 | 0.150 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.140 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.140 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2016 | 22 | 0.140 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 37 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 87 | 0.140 |
Why?
|
| Germinal Center | 1 | 2016 | 55 | 0.140 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 89 | 0.130 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 122 | 0.130 |
Why?
|
| Humans | 13 | 2024 | 89357 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 167 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 428 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1799 | 0.120 |
Why?
|
| Interferons | 1 | 2015 | 126 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 922 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2016 | 318 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2014 | 26 | 0.120 |
Why?
|
| Autoantigens | 1 | 2014 | 129 | 0.110 |
Why?
|
| Ohio | 1 | 2012 | 39 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2012 | 38 | 0.100 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 69 | 0.100 |
Why?
|
| Mycophenolic Acid | 2 | 2024 | 84 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 160 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2014 | 319 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2014 | 681 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 1242 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2012 | 249 | 0.090 |
Why?
|
| Female | 5 | 2024 | 46202 | 0.070 |
Why?
|
| Mice | 2 | 2021 | 11761 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1431 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1714 | 0.060 |
Why?
|
| Animals | 5 | 2021 | 27371 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2401 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2014 | 3385 | 0.050 |
Why?
|
| Middle Aged | 3 | 2024 | 25974 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 34 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 165 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2020 | 31 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 201 | 0.040 |
Why?
|
| Male | 4 | 2024 | 42411 | 0.040 |
Why?
|
| Rituximab | 1 | 2020 | 119 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 148 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2020 | 232 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 465 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 996 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 975 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2020 | 171 | 0.040 |
Why?
|
| Young Adult | 2 | 2024 | 6312 | 0.040 |
Why?
|
| Adolescent | 2 | 2024 | 9263 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 645 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 26607 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 1671 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 138 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 19165 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 66 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 193 | 0.030 |
Why?
|
| Monocytes | 1 | 2015 | 218 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 374 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 153 | 0.030 |
Why?
|
| Morphine | 1 | 1994 | 130 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1976 | 0.030 |
Why?
|
| Naltrexone | 1 | 1994 | 136 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3783 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 445 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 345 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2012 | 168 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8241 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 595 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1184 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1310 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1862 | 0.020 |
Why?
|
| United States | 1 | 2022 | 6989 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1994 | 415 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6811 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1840 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2496 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 2440 | 0.020 |
Why?
|
| Drug Implants | 1 | 1994 | 34 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1994 | 64 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1994 | 47 | 0.010 |
Why?
|
| Body Temperature | 1 | 1994 | 125 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1994 | 245 | 0.010 |
Why?
|
| Analgesia | 1 | 1994 | 58 | 0.010 |
Why?
|
| Weight Loss | 1 | 1994 | 227 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 1237 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 1942 | 0.010 |
Why?
|
| Rats | 1 | 1994 | 4041 | 0.000 |
Why?
|
| Time Factors | 1 | 1994 | 5338 | 0.000 |
Why?
|